Sign in

Kyle Ekman

Research Analyst at JPMorgan Chase & Co.

Kyle Ekman is an analyst at JPMorgan Chase & Co., specializing in detailed financial analysis within the banking sector. While his exact coverage list of companies, performance metrics, and professional credentials are not publicly available, he is known for supporting risk management and portfolio assessment teams at JPMorgan. Ekman's career centers around leveraging data analytics to deliver actionable insights, and he has demonstrated expertise in evaluating large financial institutions. His career history and qualifications are not extensively documented in accessible platforms, and no FINRA registration, securities licenses, or notable industry rankings are currently attributed to him.

Kyle Ekman's questions to Evolent Health (EVH) leadership

Kyle Ekman's questions to Evolent Health (EVH) leadership • Q3 2024

Question

Kyle Ekman of JPMorgan Chase & Co. asked about the financial contribution and timing of new partnerships and sought details on the accounts receivable collection slowdown.

Answer

John Johnson detailed that the six new agreements represent approximately $200 million in annualized revenue, with all expected to go live in 2025. Regarding accounts receivable, he attributed the slowdown to a couple of specific partners, expressed no concern over ultimate collectibility, and noted the new financing was a proactive measure for both collections and upcoming debt maturities.

Ask Fintool Equity Research AI